Motilal Oswal S&P 500 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
Motilal Oswal S&P 500 Index Fund (Direct) and ICICI Prudential Nifty Pharma Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 08 Sep 2026
Growth of ₹100 (rebased over the selected window)
Common period 15 Dec 2022 – 07 Sep 2026, limited by ICICI Prudential Nifty Pharma Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal S&P 500 Index Fund | ICICI Prudential Nifty Pharma Index Fund | S&P 500 | Nifty 500 |
|---|---|---|---|---|
| 15 Dec 2022 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 08 Apr 2023 | ₹101.55 | ₹95.98 | ₹105.37 | ₹93.51 |
| 30 Jul 2023 | ₹114.49 | ₹116.65 | ₹117.62 | ₹107.38 |
| 21 Nov 2023 | ₹115.18 | ₹124.05 | ₹116.49 | ₹111.68 |
| 13 Mar 2024 | ₹130.47 | ₹144.70 | ₹132.59 | ₹124.47 |
| 05 Jul 2024 | ₹141.87 | ₹158.34 | ₹142.90 | ₹145.64 |
| 26 Oct 2024 | ₹149.01 | ₹174.96 | ₹149.09 | ₹142.55 |
| 17 Feb 2025 | ₹162.11 | ₹163.62 | ₹156.96 | ₹130.85 |
| 10 Jun 2025 | ₹157.84 | ₹170.23 | ₹155.01 | ₹147.87 |
| 02 Oct 2025 | ₹181.96 | ₹169.07 | ₹172.38 | ₹145.26 |
| 23 Jan 2026 | ₹194.29 | ₹168.78 | ₹177.52 | ₹143.86 |
| 17 May 2026 | ₹217.60 | ₹191.52 | ₹190.17 | ₹142.75 |
| 07 Sep 2026 | ₹223.41 | ₹207.80 | ₹198.13 | ₹146.71 |
| Metric | Motilal Oswal · Direct NAV ₹33.66 Very High risk ★★★★☆ | ICICI Prudential · Direct NAV ₹20.82 Very High risk ★★★★★ | Category median Index Funds · 379 funds |
|---|---|---|---|
| +27.64%Best in row | +23.08% | +5.66% | |
| +25.61%Best in row | +20.83% | +7.61% | |
| +17.42% | — | +7.44% | |
| +21.33% | +21.90%Best in row | +7.57% | |
| +23.36%Best in row | +20.37% | — | |
| +17.69% | +22.08%Best in row | +12.38% | |
| +17.83% | — | +13.35% | |
| Risk | |||
| 15.40% | 15.06%Best in row | 13.67% | |
| 1.24Best in row | 0.95 | 0.17 | |
| 1.83Best in row | 1.37 | 0.23 | |
| -19.91% | -16.59%Best in row | -16.11% | |
| S&P 500 | Nifty 500 | — | |
| +4.34% | +10.55%Best in row | +0.64% | |
| 1.02 | 0.67 | 1.00 | |
| 113.0%Best in row | 109.3% | 102.2% | |
| 89.1% | 56.4%Best in row | 97.3% | |
| 0.62% | 0.51%Best in row | 0.36% | |
| ₹4,500Cr | ₹121.63Cr | ₹177.09Cr | |
| 1.00% | None | — | |
| ₹500 | ₹1.00K | — | |
| ₹500 | ₹1.00K | — | |
| 1% | 26% | 35% | |
| Rakesh Shetty | Ashwini Shinde | — | |
| 29 Apr 2020 | 15 Dec 2022 | — | |
| — | 20 | — | |
| — | 79.1% | — | |
| 0.2% | 0.0% | — | |
3 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Over the last 3 years, Motilal Oswal S&P 500 Index Fund returned +25.61% CAGR against ICICI Prudential Nifty Pharma Index Fund's +20.83%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: Motilal Oswal S&P 500 Index Fund charges 0.62% a year against ICICI Prudential Nifty Pharma Index Fund's 0.51%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Motilal Oswal S&P 500 Index Fund has shown higher volatility (+15.40% annualized vs ICICI Prudential Nifty Pharma Index Fund's +15.06%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: Motilal Oswal S&P 500 Index Fund -19.37% vs ICICI Prudential Nifty Pharma Index Fund -16.59%.
Which fund manages more money — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Motilal Oswal S&P 500 Index Fund is the larger fund: Motilal Oswal S&P 500 Index Fund manages ₹4,500Cr against ICICI Prudential Nifty Pharma Index Fund's ₹121.63Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are Motilal Oswal S&P 500 Index Fund and ICICI Prudential Nifty Pharma Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.